CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CANbridge Pharmaceuticals Inc. has announced plans to downsize its U.S. operations, including terminating its exclusive license agreement with the University of Massachusetts and negotiating the end of its Boston office lease. These steps aim to alleviate liquidity pressures without impacting the company’s overall operations or financial performance. However, CANbridge’s future as a going concern depends on securing additional financing sources.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.